guest ::
| Home > Publications database > Tailoring the Antibody Response to Aggregated Aß Using Novel Alzheimer-Vaccines > print |
| Home > Publications database > Tailoring the Antibody Response to Aggregated Aß Using Novel Alzheimer-Vaccines > print |
| 001 | 187170 | ||
| 005 | 20210129214946.0 | ||
| 024 | 7 | _ | |2 doi |a 10.1371/journal.pone.0115237 |
| 024 | 7 | _ | |2 WOS |a WOS:000348562900006 |
| 037 | _ | _ | |a FZJ-2015-00844 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 500 |
| 100 | 1 | _ | |0 P:(DE-HGF)0 |a Mandler, M. |b 0 |
| 245 | _ | _ | |a Tailoring the Antibody Response to Aggregated Aß Using Novel Alzheimer-Vaccines |
| 260 | _ | _ | |a Lawrence, Kan. |b PLoS |c 2015 |
| 336 | 7 | _ | |0 PUB:(DE-HGF)16 |2 PUB:(DE-HGF) |a Journal Article |b journal |m journal |s 1422284680_24687 |
| 336 | 7 | _ | |2 DataCite |a Output Types/Journal article |
| 336 | 7 | _ | |0 0 |2 EndNote |a Journal Article |
| 336 | 7 | _ | |2 BibTeX |a ARTICLE |
| 336 | 7 | _ | |2 ORCID |a JOURNAL_ARTICLE |
| 336 | 7 | _ | |2 DRIVER |a article |
| 520 | _ | _ | |a Recent evidence suggests Alzheimer-Disease (AD) to be driven by aggregated Aß. Capitalizing on the mechanism of molecular mimicry and applying several selection layers, we screened peptide libraries for moieties inducing antibodies selectively reacting with Aß-aggregates. The technology identified a pool of peptide candidates; two, AFFITOPES AD01 and AD02, were assessed as vaccination antigens and compared to Aβ1-6, the targeted epitope. When conjugated to Keyhole Limpet Hemocyanin (KLH) and adjuvanted with aluminum, all three peptides induced Aß-targeting antibodies (Abs). In contrast to Aß1-6, AD01- or AD02-induced Abs were characterized by selectivity for aggregated forms of Aß and absence of reactivity with related molecules such as Amyloid Precursor Protein (APP)/ secreted APP-alpha (sAPPa). Administration of AFFITOPE-vaccines to APP-transgenic mice was found to reduce their cerebral amyloid burden, the associated neuropathological alterations and to improve their cognitive functions. Thus, the AFFITOME-technology delivers vaccines capable of inducing a distinct Ab response. Their features may be beneficial to AD-patients, a hypothesis currently tested within a phase-II-study. |
| 536 | _ | _ | |0 G:(DE-HGF)POF3-553 |a 553 - Physical Basis of Diseases (POF3-553) |c POF3-553 |f POF III |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, juser.fz-juelich.de |
| 700 | 1 | _ | |0 P:(DE-HGF)0 |a Santic, Radmila |b 1 |
| 700 | 1 | _ | |0 P:(DE-HGF)0 |a Gruber, Petra |b 2 |
| 700 | 1 | _ | |0 P:(DE-Juel1)131993 |a Cinar, Yeliz |b 3 |u fzj |
| 700 | 1 | _ | |0 P:(DE-HGF)0 |a Pichler, Dagmar |b 4 |
| 700 | 1 | _ | |0 P:(DE-HGF)0 |a Funke, Susanne Aileen |b 5 |
| 700 | 1 | _ | |0 P:(DE-Juel1)132029 |a Willbold, Dieter |b 6 |u fzj |
| 700 | 1 | _ | |0 P:(DE-HGF)0 |a Schneeberger, Achim |b 7 |e Corresponding Author |
| 700 | 1 | _ | |0 P:(DE-HGF)0 |a Schmidt, Walter |b 8 |
| 700 | 1 | _ | |0 P:(DE-HGF)0 |a Mattner, Frank |b 9 |
| 773 | _ | _ | |0 PERI:(DE-600)2267670-3 |a 10.1371/journal.pone.0115237 |g Vol. 10, no. 1, p. e0115237 - |n 1 |p e0115237 - |t PLoS one |v 10 |x 1932-6203 |y 2015 |
| 856 | 4 | _ | |u http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0115237 |
| 856 | 4 | _ | |u https://juser.fz-juelich.de/record/187170/files/FZJ-2015-00844.pdf |y OpenAccess |
| 909 | C | O | |o oai:juser.fz-juelich.de:187170 |p openaire |p open_access |p driver |p VDB |p dnbdelivery |
| 910 | 1 | _ | |0 I:(DE-HGF)0 |6 P:(DE-Juel1)131993 |a External Institute |b 3 |k Extern |
| 910 | 1 | _ | |0 I:(DE-588b)5008462-8 |6 P:(DE-Juel1)132029 |a Forschungszentrum Jülich GmbH |b 6 |k FZJ |
| 913 | 0 | _ | |0 G:(DE-HGF)POF2-452 |1 G:(DE-HGF)POF2-450 |2 G:(DE-HGF)POF2-400 |a DE-HGF |b Schlüsseltechnologien |l BioSoft: Makromolekulare Systeme und biologische Informationsverarbeitung |v Structural Biology |x 0 |
| 913 | 1 | _ | |0 G:(DE-HGF)POF3-553 |1 G:(DE-HGF)POF3-550 |2 G:(DE-HGF)POF3-500 |a DE-HGF |b Key Technologies |l BioSoft – Fundamentals for future Technologies in the fields of Soft Matter and Life Sciences |v Physical Basis of Diseases |x 0 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF3 |
| 914 | 1 | _ | |y 2015 |
| 915 | _ | _ | |0 LIC:(DE-HGF)CCBY4 |2 HGFVOC |a Creative Commons Attribution CC BY 4.0 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0100 |2 StatID |a JCR |
| 915 | _ | _ | |0 StatID:(DE-HGF)0111 |2 StatID |a WoS |b Science Citation Index Expanded |
| 915 | _ | _ | |0 StatID:(DE-HGF)0150 |2 StatID |a DBCoverage |b Web of Science Core Collection |
| 915 | _ | _ | |0 StatID:(DE-HGF)0199 |2 StatID |a DBCoverage |b Thomson Reuters Master Journal List |
| 915 | _ | _ | |0 StatID:(DE-HGF)0200 |2 StatID |a DBCoverage |b SCOPUS |
| 915 | _ | _ | |0 StatID:(DE-HGF)0300 |2 StatID |a DBCoverage |b Medline |
| 915 | _ | _ | |0 StatID:(DE-HGF)0310 |2 StatID |a DBCoverage |b NCBI Molecular Biology Database |
| 915 | _ | _ | |0 StatID:(DE-HGF)0500 |2 StatID |a DBCoverage |b DOAJ |
| 915 | _ | _ | |0 StatID:(DE-HGF)1040 |2 StatID |a DBCoverage |b Zoological Record |
| 915 | _ | _ | |0 StatID:(DE-HGF)1050 |2 StatID |a DBCoverage |b BIOSIS Previews |
| 915 | _ | _ | |0 StatID:(DE-HGF)9900 |2 StatID |a IF < 5 |
| 920 | _ | _ | |l yes |
| 920 | 1 | _ | |0 I:(DE-Juel1)ICS-6-20110106 |k ICS-6 |l Strukturbiochemie |x 0 |
| 980 | 1 | _ | |a FullTexts |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-Juel1)ICS-6-20110106 |
| 980 | _ | _ | |a UNRESTRICTED |
| 980 | _ | _ | |a FullTexts |
| 981 | _ | _ | |a I:(DE-Juel1)IBI-7-20200312 |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|